Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2017 6
2018 5
2019 6
2020 5
2021 5
2022 2
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, Dalle S, Arance A, Grob JJ, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV; RELATIVITY-047 Investigators. Tawbi HA, et al. N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970. N Engl J Med. 2022. PMID: 34986285 Free PMC article. Clinical Trial.
Targeted treatment of advanced NRAS-mutated melanoma.
Koelblinger P, Dummer R. Koelblinger P, et al. Oncotarget. 2017 Sep 29;8(49):84616-84617. doi: 10.18632/oncotarget.21388. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156659 Free PMC article. No abstract available.
[Rückblick: ÖGDV Jahrestagung 2022].
Koelblinger P, Bauer JW. Koelblinger P, et al. J Dtsch Dermatol Ges. 2023 May;21(5):567-568. doi: 10.1111/ddg.15082_g. J Dtsch Dermatol Ges. 2023. PMID: 37183742 German. No abstract available.
MEK inhibition and immune responses in advanced melanoma.
Dummer R, Ramelyte E, Schindler S, Thürigen O, Levesque MP, Koelblinger P. Dummer R, et al. Among authors: koelblinger p. Oncoimmunology. 2017 Aug 10;6(8):e1335843. doi: 10.1080/2162402X.2017.1335843. eCollection 2017. Oncoimmunology. 2017. PMID: 28919996 Free PMC article. Review.
Oestrogen receptor expression in melanoma.
Ramelyte E, Koelblinger P, Dummer R. Ramelyte E, et al. Among authors: koelblinger p. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1399-1400. doi: 10.1111/jdv.14520. J Eur Acad Dermatol Venereol. 2017. PMID: 28815749 No abstract available.
39 results